These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Cost of palliative external beam radiotherapy (EBRT) use for bone metastases secondary to prostate cancer. Nickman NA; Ye X; Gaffney DK; Barney RB; Biskupiak JE; Okano GJ; Lee VC; Arellano J J Community Support Oncol; 2015 Mar; 13(3):95-103. PubMed ID: 25880672 [TBL] [Abstract][Full Text] [Related]
46. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
47. Effectiveness of strontium-89 palliative therapy in patients with painful bone metastases. Zorga P; Birkenfeld B; Listewnik MH; Piwowarska-Bilska H Ann Acad Med Stetin; 2011; 57(1):49-53; discussion 53. PubMed ID: 22593991 [TBL] [Abstract][Full Text] [Related]
48. Breast cancer with skeletal metastases at initial diagnosis. Distinctive clinical characteristics and favorable prognosis. Sherry MM; Greco FA; Johnson DH; Hainsworth JD Cancer; 1986 Jul; 58(1):178-82. PubMed ID: 2423224 [TBL] [Abstract][Full Text] [Related]
49. Early Improvement in Pain and Functional Outcome but Not Quality of Life After Surgery for Metastatic Long Bone Disease. Nooh A; Goulding K; Isler MH; Mottard S; Arteau A; Dion N; Turcotte R Clin Orthop Relat Res; 2018 Mar; 476(3):535-545. PubMed ID: 29529637 [TBL] [Abstract][Full Text] [Related]
50. Routine clinical data predict survival after palliative radiotherapy: an opportunity to improve end of life care. Williams M; Woolf D; Dickson J; Hughes R; Maher J; Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):668-73. PubMed ID: 23830971 [TBL] [Abstract][Full Text] [Related]
51. Palliative radiotherapy for bone metastases in the last 3 months of life: worthwhile or futile? Dennis K; Wong K; Zhang L; Culleton S; Nguyen J; Holden L; Jon F; Tsao M; Danjoux C; Barnes E; Sahgal A; Zeng L; Koo K; Chow E Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):709-15. PubMed ID: 21665446 [TBL] [Abstract][Full Text] [Related]
52. Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: single institution experience. Fosså SD Br J Urol; 1994 Sep; 74(3):345-51. PubMed ID: 7524999 [TBL] [Abstract][Full Text] [Related]
54. Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial. Logothetis CJ; Basch E; Molina A; Fizazi K; North SA; Chi KN; Jones RJ; Goodman OB; Mainwaring PN; Sternberg CN; Efstathiou E; Gagnon DD; Rothman M; Hao Y; Liu CS; Kheoh TS; Haqq CM; Scher HI; de Bono JS Lancet Oncol; 2012 Dec; 13(12):1210-7. PubMed ID: 23142059 [TBL] [Abstract][Full Text] [Related]
55. Radiotherapy for metastases to the mandible in children. Deutsch M; Wollman MR J Oral Maxillofac Surg; 2002 Mar; 60(3):269-71. PubMed ID: 11887137 [TBL] [Abstract][Full Text] [Related]
56. Palliative radiotherapy in the treatment of skeletal metastases. Saarto T; Janes R; Tenhunen M; Kouri M Eur J Pain; 2002; 6(5):323-30. PubMed ID: 12160506 [TBL] [Abstract][Full Text] [Related]
57. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376 [TBL] [Abstract][Full Text] [Related]
58. Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial. Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H Radiat Oncol; 2018 Oct; 13(1):212. PubMed ID: 30376859 [TBL] [Abstract][Full Text] [Related]
59. Radiation Therapy and Palliative Care Prolongs the Survival of Hepatocellular Carcinoma Patients with Bone Metastases. Sakaguchi M; Maebayashi T; Aizawa T; Ishibashi N; Fukushima S; Saito T Intern Med; 2016; 55(9):1077-83. PubMed ID: 27150858 [TBL] [Abstract][Full Text] [Related]
60. Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance. Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A Int J Circumpolar Health; 2017; 76(1):1270080. PubMed ID: 28452680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]